Atlas Trials

Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone

Clinical trial NCT00504413 · UNKNOWN

Trial details

NCT number
NCT00504413
Sponsor
University of Washington
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Substance-Related Disorders
Start date
2007-07-01
Primary completion
2011-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.